Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)
| CAPS Rating |
|
|---|---|
| Open | $9.82 |
| Previous Close | $9.99 |
| Daily Range | $9.31 - $9.85 |
| 52-Week Range | $4.50 - $10.50 |
| Market Cap | $320.56M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 105,894 |
| Average Daily Volume | 0 |
PGNX
VS S&P 500 (SPY)
How do you think PGNX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PGNX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PGNX News and Commentary
- Salix Scores with Oral Relistor - Analyst Blog – NASDAQ
- 2-Star Stocks Poised to Plunge: Progenics? – The Motley Fool
- Salix Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies – The Motley Fool
- Don't Get Too Worked Up Over InterMune's Earnings – The Motley Fool
- Is Seattle Genetics the Perfect Stock? – The Motley Fool
- The Big Bet on Seattle Genetics – The Motley Fool
- FDA Insider Trading: Time for an Overhaul? – SeekingAlpha
- Future Biotech Superstars – SeekingAlpha
- Paul Tudor Jones' Favorite Long Positions – SeekingAlpha
- Drug Makers Warn Of Potential Contamination of Alcohol Pads – SmartMoney
- Drug Development Spotlight: The mTOR's New Clothes? – SeekingAlpha
- Clinical Trial Positive! Shares Just Barely – The Motley Fool
- This Bad News Could've Been Worse – The Motley Fool
- Is This Cash Machine Running on Empty? – The Motley Fool
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? – SeekingAlpha
- So Long, See You in Arbitration – The Motley Fool
- Wyeth Can't Save Pfizer – The Motley Fool
RSS Headlines
Fool UK
